Cytosine β-D-Arabinofuranoside
Cat.No:C8040 Solarbio
CAS:147-94-4
Molecular Formula:C9H13N3O5
Molecular Weight:243.22
Appearance:White Powder
Storage:Store at 2-8℃,2 years
Qty:
Size:
{{cart_num}}
My Cart>
Biochemical Reagents >
Nucleic Acids & Nucleotides & Derivatives >
Cytosine β-D-ArabinofuranosideCAS:147-94-4
Molecular Formula:C9H13N3O5
Molecular Weight:243.22
Appearance:White Powder
Storage:Store at 2-8℃,2 years
Qty:
Size:
Name | Cytosine β-D-arabinofuranoside |
CAS | 147-94-4 |
Molecular Formula | C9H13N3O5 |
Molecular Weight | 243.22 |
Storage | Store at 2-8℃,2 years |
Appearance | White Powder |
Solubility | 50 mg/mL Water |
Unit | Bottle |
Specification | 1g 5g 25g 100g |
Product introduction
Cytarabine, when complex into DNA, inhibits DNA replication by forming cleavable complexes with topoisomerase I, which causes DNA breaks, but does not inhibit RNA synthesis. It is used in cancer research, cell signaling and neuroscience, cell biology, etc.
Physical properties
white powder; When dissolved in water, it was a colorless clear liquid, and the reference concentration was 50 mg/ml.
Note:Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2
Click to check >>Author:Gao Zhan, Li Zhicai, Li Xiaowei, Xiao Jun, Li Cuiying
IF:5.5000
Publish_to:Frontiers in Cell and Developmental Biology
PMID:37325570
Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
Click to check >>Author:Hui Liang, Qi-Li Zheng, Peng Fang, Jian Zhang, Tuo
IF:4.2590
Publish_to:Scientific Reports 7, Article number: 40361 (2017)
PMID:28098170